Aberrant Expression of miR-1301 in Human Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
• miR-1301 is a recently identified miRNA with a significant role in tumorigenesis.
• Aberrant miRNA expression is a hallmark of many cancers, affecting various cellular processes.

Purpose of the Study:

• To systematically review the abnormal expression and prognostic value of miR-1301 across diverse cancer types.
• To elucidate the molecular mechanisms, including target genes, ceRNA networks, and signaling pathways, involving miR-1301 in cancer.
• To explore the potential of miR-1301 as a biomarker and therapeutic target in oncology.

Main Methods:

• Comprehensive literature review of studies investigating miR-1301 in cancer.
• Analysis of miR-1301 expression patterns in various tumor tissues.
• Examination of miR-1301's interactions within ceRNA networks (competing endogenous RNA networks) involving circRNAs and lncRNAs.
• Identification of miR-1301-regulated signaling pathways crucial for cancer development and progression.

Main Results:

• miR-1301 is abnormally expressed in at least 14 types of tumors.
• It targets 23 genes and participates in 6 key signaling pathways, influencing tumor cell proliferation, invasion, metastasis, apoptosis, and angiogenesis.
• Dysregulated miR-1301 expression correlates with poor patient prognosis across multiple cancers.
• miR-1301 modulates the efficacy of chemotherapy drugs like cisplatin and targeted therapies such as imatinib.

Conclusions:

• miR-1301 is a significant onco-miRNA with a broad impact on cancer biology.
• Its abnormal expression and regulatory network highlight its prognostic value and potential as a therapeutic target.
• Further research into miR-1301 mechanisms could lead to novel diagnostic and therapeutic strategies for cancer patients.